EZH2 and Miyoshi myopathy: We evaluated the genome-wide distribution of H3K27me3, H3K27ac, H3K4me1 and H3K4me3 by ChIP-seq, and high-density DNAme array (Illumina Infinium MethylationEPIC) in MM cells treated with the EZH2 inhibitor UNC1999, the DNAme inhibitor 5-azacytidine, or their combination.